>
Regulatory > Human and Ecological Risk Assessment
Human and Ecological Risk Assessment
Risk Assessments
ICTM’s Risk Assessment Unit performs risk assessments to support regulatory actions, facility permitting, and risk management needs. Our broad communication expertise assists clients with report language aimed at reducing misinterpretation of risk assessment results, and potential future liabilities.
ICTM’s risk assessment expertise has been applied in diverse regulatory programs:
- RCRA
- CWA
- FIFRA
- FQPA
- CAA
- SARA
- CERCLA
Our toxicological expertise can be instrumental in identifying appropriate values for specific assessment parameters.
Human Health Risk Assessments apply the Lakes Environmental IRAP software that facilitates completion of complex multi-pathway direct and indirect risk assessments. This software directly incorporates the EPA Human Health Risk Assessment Protocol currently required by regulatory permitting process.
Ecological Risk Assessments can be tailored to an assessment approach that best suits the needs of the client. ICTM’s screening level approach to ecological risk assessments has been accepted by several EPA Regional offices and state agencies. When more complex ecological assessments are required, ICTM can apply the EPA Screening Level Ecological Risk Assessment Protocol using the Lakes Environmental software as part of the regulatory process.
ICTM also provides a variety of fate and transport models to meet your special needs, including:
- EPA Air Dispersion
- EPA IEM-2M (mercury fate & transport)
- IRAP Human Health Risk Assessment
- SLERAP Risk Assessment
Risk Assessment Expertise
ICTM Risk Assessment expertise has been used by diverse clients.
| Catalytica Pharmaceutical |
Multipathway Human Health Risk Assessment |
| Reilly Industries |
Risk Assessment Protocol; Air Dispersion Modeling Protocol; Multipathway Human Health Risk Assessment; Ecological Risk Assessment |
| Mallinckrodt Chemical |
Risk Assessment/Air Dispersion Model Protocol; Multipathway Human Health Risk Assessment |
| Arizona Chemical |
Risk Assessment/Air Dispersion Model Protocol; Multipathway Human Health Risk Assessment |
| Solite Corporation |
Risk Assessment/Air Dispersion Model Protocol; Multipathway Human Health Risk Assessment; Ecological Risk Assessment; Critique of North Carolina Risk Assessment Protocol Guidance |
| ASARCO |
Aquatic Risk Assessment |
| Masonite Corporation |
Air Dispersion Modeling and Direct Risk Assessment |
| OSCO |
Qualitative Inhalation Exposure Assessment |
| Louisiana-Pacific Corporation |
Qualitative Inhalation Exposure Assessment |
| Dupont Company |
Direct Risk Assessment for Contaminated Soil/Groundwater Exposure |
| GlaxoSmithKline |
Risk Assessment/Air Dispersion Model Protocol; Multipathway Human Health Risk Assessment; Ecological Risk Assessment |
| Giant Cement Holding Company |
Risk Assessment/Air Dispersion Model Protocol; Multipathway Human Health Risk Assessment; Ecological Risk Assessment |
| Day Environmental |
Risk Assessment for Property Clearance |
| Weinberg, Bergeson & Neuman |
Review of EPA Triazine Risk Assessment |
